Human mesenchymal stem cells: A bank perspective on the isolation, characterization and potential of alternative sources for the regeneration of musculoskeletal tissues

Journal of Cellular Physiology

Volumn 228, Issue 4, 2013, Pages 680-687

  Moroni, Lorenzo ^a   Fornasari, Pier Maria ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL STRUCTURE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MUSCULOSKELETAL REGENERATION; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; HUMANS; MESENCHYMAL STROMAL CELLS; MUSCLE, SKELETAL; REGENERATION; REGENERATIVE MEDICINE;

EID: 84871699400     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24223     Document Type: Review

References (139)

1. Abumaree MH, Al Jumah MA, Kalionis B, Jawdat D, Al Khaldi A, Altalabani AA, Knawy BA. 2012. Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta. Stem Cell Rev Epub ahead of printing, May 25.
2. Agung M, Ochi M, Yanada S, Adachi N, Izuta Y, Yamasaki T, Toda K. 2006. Mobilization of bone marrow-derived mesenchymal stem cells into the injured tissues after intraarticular injection and their contribution to tissue regeneration. Knee Surg Sports Traumatol Arthrosc 14:1307-1314.
3. Ahrens N, Tormin A, Paulus M, Roosterman D, Salama A, Krenn V, Neumann U, Scheding S. 2004. Mesenchymal stem cell content of human vertebral bone marrow. Transplantation 78:925-929.
4. Alhadlaq A, Tang M, Mao JJ. 2005. Engineered adipose tissue from human mesenchymal stem cells maintains predefined shape and dimension: Implications in soft tissue augmentation and reconstruction. Tissue Eng 11:556-566.
5. Al-Nbaheen M, Vishnubalaji R, Ali D, Bouslimi A, Al-Jassir F, Megges M, Prigione A, Adjaye J, Kassem M, Aldahmash A. 2012. Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem cell Rev Epub ahead of printing, April 14.
6. 2007. Regulation(EC) No 1394/2007 of the European parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004. Official J Eur Union 324:121-137.
7. 2011. Reflection paper on stem cell-based medicinal products. European Medicines Agency: 1-14.
8. Bacenkova D, Rosocha J, Tothova T, Rosocha L, Sarissky M. 2011. Isolation and basic characterization of human term amnion and chorion mesenchymal stromal cells. Cytotherapy 13:1047-1056.
9. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG. 2003. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 89:1235-1249.
10. Battula VL, Bareiss PM, Treml S, Conrad S, Albert I, Hojak S, Abele H, Schewe B, Just L, Skutella T, Buhring HJ. 2007. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75:279-291.
11. Bensaid W, Triffitt JT, Blanchat C, Oudina K, Sedel L, Petite H. 2003. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24:2497-2502.
12. Bernardo ME, Emons JA, Karperien M, Nauta AJ, Willemze R, Roelofs H, Romeo S, Marchini A, Rappold GA, Vukicevic S, Locatelli F, Fibbe WE. 2007. Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. Connect Tissue Res 48:132-140.
13. Bieback K, Kern S, Kluter H, Eichler H. 2004. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells (Dayton, Ohio) 22:625-634.
14. Burdick JA, Vunjak-Novakovic G. 2009. Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A 15:205-219.
15. Can A, Karahuseyinoglu S. 2007. Concise review: Human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells (Dayton, Ohio) 25:2886-2895.
16. Caplan AI. 1991. Mesenchymal stem cells. J Orthop Res 9:641-650.
17. Caplan AI. 2009. Why are MSCs therapeutic? New data: New insight. J Pathol 217:318-324.
18. Caplan AI, Dennis JE. 2006. Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076-1084.
19. Cassiede P, Dennis JE, Ma F, Caplan AI. 1996. Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro. J Bone Miner Res 11:1264-1273.
20. Cavallo C, Cuomo C, Fantini S, Ricci F, Tazzari PL, Lucarelli E, Donati D, Facchini A, Lisignoli G, Fornasari PM, Grigolo B, Moroni L. 2011. Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies. J Cell Biochem 112:1418-1430.
21. Chamberlain G, Fox J, Ashton B, Middleton J. 2007. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells (Dayton, Ohio) 25:2739-2749.
22. Chen J, Sotome S, Wang J, Orii H, Uemura T, Shinomiya K. 2005. Correlation of in vivo bone formation capability and in vitro differentiation of human bone marrow stromal cells. J Med Dent Sci 52:27-34.
23. Chen CP, Lee MY, Huang JP, Aplin JD, Wu YH, Hu CS, Chen PC, Li H, Hwang SM, Liu SH, Yang YC. 2008. Trafficking of multipotent mesenchymal stromal cells from maternal circulation through the placenta involves vascular endothelial growth factor receptor-1 and integrins. Stem Cells (Dayton, Ohio) 26:550-561.
24. Cohena Y, Nagler A. 2003. Hematopoietic stem-cell transplantation using umbilical-cord blood. Leuk Lymphoma 44:1287-1299.
25. Colter DC, Class R, DiGirolamo CM, Prockop DJ. 2000. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97:3213-3218.
26. Conget PA, Minguell JJ. 1999. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181:67-73.
27. Das R, Jahr H, van Osch GJ, Farrell E. 2010. The role of hypoxia in bone marrow-derived mesenchymal stem cells: Considerations for regenerative medicine approaches. Tissue Eng Part B Rev 16:159-168.
28. De Coppi P, Bartsch G, Jr., Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A. 2007. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100-106.
29. Deuse T, Stubbendorff M, Tang-Quan K, Phillips N, Kay MA, Eiermann T, Phan TT, Volk HD, Reichenspurner H, Robbins RC, Schrepfer S. 2011. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 20:655-667.
30. Erices A, Conget P, Minguell JJ. 2000. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109:235-242.
31. Fan CG, Zhang QJ, Zhou JR. 2011. Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev 7:195-207.
32. Fariha MM, Chua KH, Tan GC, Tan AE, Hayati AR. 2011. Human chorion-derived stem cells: Changes in stem cell properties during serial passage. Cytotherapy 13:582-593.
33. Fehrer C, Brunauer R, Laschober G, Unterluggauer H, Reitinger S, Kloss F, Gully C, Gassner R, Lepperdinger G. 2007. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 6:745-757.
34. Fennema EM, Renard AJ, Leusink A, van Blitterswijk CA, de Boer J. 2009. The effect of bone marrow aspiration strategy on the yield and quality of human mesenchymal stem cells. Acta Orthop 80:618-621.
35. Frid MG, Brunetti JA, Burke DL, Carpenter TC, Davie NJ, Reeves JT, Roedersheimer MT, van Rooijen N, Stenmark KR. 2006. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol 168:659-669.
36. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. 1974. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17:331-340.
37. Gang EJ, Jeong JA, Hong SH, Hwang SH, Kim SW, Yang IH, Ahn C, Han H, Kim H. 2004. Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells (Dayton, Ohio) 22:617-624.
38. Gindraux F, Selmani Z, Obert L, Davani S, Tiberghien P, Herve P, Deschaseaux F. 2007. Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a molecule. Cell Tissue Res 327:471-483.
39. Goodwin HS, Bicknese AR, Chien SN, Bogucki BD, Quinn CO, Wall DA. 2001. Multilineage differentiation activity by cells isolated from umbilical cord blood: Expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 7:581-588.
40. Gotherstrom C, Ringden O, Tammik C, Zetterberg E, Westgren M, Le Blanc K. 2004. Immunologic properties of human fetal mesenchymal stem cells. Am J Obstet Gynecol 190:239-245.
41. Grein TA, Freimark D, Weber C, Hudel K, Wallrapp C, Czermak P. 2010. Alternatives to dimethylsulfoxide for serum-free cryopreservation of human mesenchymal stem cells. Int J Artif Organs 33:370-380.
42. Grigorian AS, Kruglyakov PV, Taminkina UA, Efimova OA, Pendina AA, Voskresenskaya AV, Kuznetsova TV, Polyntsev DG. 2010. Alterations of cytological and karyological profile of human mesenchymal stem cells during in vitro culturing. Bull Exp Biol Med 150:125-130.
43. Gronthos S, Simmons PJ, Graves SE, Robey PG. 2001. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 28:174-181.
44. Gronthos S, Brahim J, Li W, Fisher LW, Cherman N, Boyde A, DenBesten P, Robey PG, Shi S. 2002. Stem cell properties of human dental pulp stem cells. J Dent Res 81:531-535.
45. Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Panganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, Lane NE. 2012. Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med 18:456-462.
46. Guillot PV, De Bari C, Dell'Accio F, Kurata H, Polak J, Fisk NM. 2008. Comparative osteogenic transcription profiling of various fetal and adult mesenchymal stem cell sources. Differentiation 76:946-957.
47. Hattori H, Sato M, Masuoka K, Ishihara M, Kikuchi T, Matsui T, Takase B, Ishizuka T, Kikuchi M, Fujikawa K. 2004. Osteogenic potential of human adipose tissue-derived stromal cells as an alternative stem cell source. Cells Tissues Organs 178:2-12.
48. Hayani A, Lampeter E, Viswanatha D, Morgan D, Salvi SN. 2007. First report of autologous cord blood transplantation in the treatment of a child with leukemia. Pediatrics 119:e296-e300.
49. Haynesworth SE, Baber MA, Caplan AI. 1992. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13:69-80.
50. Hori J, Deie M, Kobayashi T, Yasunaga Y, Kawamata S, Ochi M. 2011. Articular cartilage repair using an intra-articular magnet and synovium-derived cells. J Orthop Res 29:531-538.
51. Hwang NS, Varghese S, Lee HJ, Zhang Z, Ye Z, Bae J, Cheng L, Elisseeff J. 2008. In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci USA 105:20641-20646.
52. Im GI, Shin YW, Lee KB. 2005. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis and cartilage/OARS, Osteoarthritis Res Soc 13:845-853.
53. Im GI, Ko JY, Lee JH. 2012. Chondrogenesis of adipose stem cells in a porous polymer scaffold: Influence of the pore size. Cell Transplant Epub ahead of printing, April 10.
54. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
55. Jungebluth P, Alici E, Baiguera S, Le Blanc K, Blomberg P, Bozoky B, Crowley C, Einarsson O, Grinnemo KH, Gudbjartsson T, Le Guyader S, Henriksson G, Hermanson O, Juto JE, Leidner B, Lilja T, Liska J, Luedde T, Lundin V, Moll G, Nilsson B, Roderburg C, Stromblad S, Sutlu T, Teixeira AI, Watz E, Seifalian A, Macchiarini P. 2011. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: A proof-of-concept study. Lancet 378:1997-2004.
56. Jurgens WJ, Oedayrajsingh-Varma MJ, Helder MN, Zandiehdoulabi B, Schouten TE, Kuik DJ, Ritt MJ, van Milligen FJ. 2008. Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: Implications for cell-based therapies. Cell Tissue Res 332:415-426.
57. Kaltz N, Funari A, Hippauf S, Delorme B, Noel D, Riminucci M, Jacobs VR, Haupl T, Jorgensen C, Charbord P, Peschel C, Bianco P, Oostendorp RA. 2008. In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells (Dayton, Ohio) 26:2419-2424.
58. Kang JM, Kang SW, La WG, Yang YS, Kim BS. 2010. Enhancement of in vivo bone regeneration efficacy of osteogenically undifferentiated human cord blood mesenchymal stem cells. J Biomed Mater Res A 93:666-672.
59. Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, Tukun A, Uckan D, Can A. 2007. Biology of stem cells in human umbilical cord stroma: In situ and in vitro surveys. Stem Cells (Dayton, Ohio) 25:319-331.
60. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K. 2006. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells (Dayton, Ohio) 24:1294-1301.
61. Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F III. 2011. Concise review: Dissecting a discrepancy in the literature: Do mesenchymal stem cells support or suppress tumor growth? Stem Cells 29:11-19.
62. Kluth SM, Buchheiser A, Houben AP, Geyh S, Krenz T, Radke TF, Wiek C, Hanenberg H, Reinecke P, Wernet P, Kogler G. 2010. DLK-1 as a marker to distinguish unrestricted somatic stem cells and mesenchymal stromal cells in cord blood. Stem Cells Dev 19:1471-1483.
63. Kocaoemer A, Kern S, Kluter H, Bieback K. 2007. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells (Dayton, Ohio) 25:1270-1278.
64. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N, Liedtke S, Sorg RV, Fischer J, Rosenbaum C, Greschat S, Knipper A, Bender J, Degistirici O, Gao J, Caplan AI, Colletti EJ, Almeida-Porada G, Muller HW, Zanjani E, Wernet P. 2004. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 200:123-135.
65. Kranz A, Wagner DC, Kamprad M, Scholz M, Schmidt UR, Nitzsche F, Aberman Z, Emmrich F, Riegelsberger UM, Boltze J. 2010. Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats. Brain Res 1315:128-136.
66. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stevens CE, Rubinstein P, Kurtzberg J. 2001. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344:1815-1822.
67. Le Blanc K, Ringden O. 2005. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11:321-334.
68. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. 2003. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31:890-896.
69. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringden O. 2008. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1579-1586.
70. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH. 2004. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103:1669-1675.
71. Lee KB, Hui JH, Song IC, Ardany L, Lee EH. 2007. Injectable mesenchymal stem cell therapy for large cartilage defects-a porcine model. Stem Cells (Dayton, Ohio) 25:2964-2971.
72. Lee CH, Cook JL, Mendelson A, Moioli EK, Yao H, Mao JJ. 2010. Regeneration of the articular surface of the rabbit synovial joint by cell homing: A proof of concept study. Lancet 376:440-448.
73. Li X, Ling W, Pennisi A, Wang Y, Khan S, Heidaran M, Pal A, Zhang X, He S, Zeitlin A, Abbot S, Faleck H, Hariri R, Shaughnessy JD, Jr., van Rhee F, Nair B, Barlogie B, Epstein J, Yaccoby S. 2011. Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone. Stem Cells (Dayton, Ohio) 29:263-273.
74. Liedtke S, Buchheiser A, Bosch J, Bosse F, Kruse F, Zhao X, Santourlidis S, Kogler G. 2010. The HOX Code as a "biological fingerprint" to distinguish functionally distinct stem cell populations derived from cord blood. Stem Cell Res 5:40-50.
75. Liu G, Li Y, Sun J, Zhou H, Zhang W, Cui L, Cao Y. 2010a. In vitro and in vivo evaluation of osteogenesis of human umbilical cord blood-derived mesenchymal stem cells on partially demineralized bone matrix. Tissue Eng Part A 16:971-982.
76. Liu SH, Huang JP, Lee RK, Huang MC, Wu YH, Chen CY, Chen CP. 2010b. Paracrine factors from human placental multipotent mesenchymal stromal cells protect endothelium from oxidative injury via STAT3 and manganese superoxide dismutase activation. Biol Reprod 82:905-913.
77. Lutolf MP, Gilbert PM, Blau HM. 2009. Designing materials to direct stem-cell fate. Nature 462:433-441.
78. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. 1998. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4:415-428.
79. Magatti M, De Munari S, Vertua E, Parolini O. 2012. Amniotic membrane-derived cells inhibit proliferation of cancer cell lines by inducing cell cycle arrest. J Cell Mol Med 16:2208-2218.
80. Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F. 2001. Isolation of human mesenchymal stem cells: Bone marrow versus umbilical cord blood. Haematologica 86:1099-1100.
81. Markway BD, Tan GK, Brooke G, Hudson JE, Cooper-White JJ, Doran MR. 2010. Enhanced chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in low oxygen environment micropellet cultures. Cell Transplant 19:29-42.
82. Merceron C, Portron S, Masson M, Lesoeur J, Fellah BH, Gauthier O, Geffroy O, Weiss P, Guicheux J, Vinatier C. 2011. The effect of two and three dimensional cell culture on the chondrogenic potential of human adipose-derived mesenchymal stem cells after subcutaneous transplantation with an injectable hydrogel. Cell Transplant Epub ahead of printing, February 3.
83. Moon JH, Lee JR, Jee BC, Suh CS, Kim SH, Lim HJ, Kim HK. 2008. Successful vitrification of human amnion-derived mesenchymal stem cells. Hum Reprod 23:1760-1770.
84. Mueller SM, Glowacki J. 2001. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 82:583-590.
85. Nakahara H, Dennis JE, Bruder SP, Haynesworth SE, Lennon DP, Caplan AI. 1991. In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res 195:492-503.
86. Nikitina VA, Osipova EY, Katosova LD, Rumyantsev SA, Skorobogatova EV, Shamanskaya TV, Bochkov NP. 2011. Study of genetic stability of human bone marrow multipotent mesenchymal stromal cells. Bull Exp Biol Med 150:627-631.
87. Nishida S, Endo N, Yamagiwa H, Tanizawa T, Takahashi HE. 1999. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J Bone Miner Metab 17:171-177.
88. Noel D, Caton D, Roche S, Bony C, Lehmann S, Casteilla L, Jorgensen C, Cousin B. 2008. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 314:1575-1584.
89. Ooi J. 2006. The efficacy of unrelated cord blood transplantation for adult myelodysplastic syndrome. Leuk Lymphoma 47:599-602.
90. Park KS, Kim YS, Kim JH, Choi B, Kim SH, Tan AH, Lee MS, Lee MK, Kwon CH, Joh JW, Kim SJ, Kim KW. 2010. Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation. Transplantation 89:509-517.
91. Parolini O, Alviano F, Bagnara GP, Bilic G, Buhring HJ, Evangelista M, Hennerbichler S, Liu B, Magatti M, Mao N, Miki T, Marongiu F, Nakajima H, Nikaido T, Portmann-Lanz CB, Sankar V, Soncini M, Stadler G, Surbek D, Takahashi TA, Redl H, Sakuragawa N, Wolbank S, Zeisberger S, Zisch A, Strom SC. 2008. CONCISE REVIEW: Isolation and characterization of cells from human term placenta: Outcome of the first international workshop on placenta derived stem cells. Stem Cells (Dayton, Ohio) 26:300-311.
92. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. 2004. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103:1662-1668.
93. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
94. Poloni A, Maurizi G, Babini L, Serrani F, Berardinelli E, Mancini S, Costantini B, Discepoli G, Leoni P. 2011. Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion. Cell Transplant 20:643-654.
95. Ponte AL, Marais E, Gallay N, Langonne A, Delorme B, Herault O, Charbord P, Domenech J. 2007. The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells (Dayton, Ohio) 25:1737-1745.
96. Potier E, Ferreira E, Meunier A, Sedel L, Logeart-Avramoglou D, Petite H. 2007. Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death. Tissue Eng 13:1325-1331.
97. Prather WR, Toren A, Meiron M, Ofir R, Tschope C, Horwitz EM. 2009. The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. Cytotherapy 11:427-434.
98. Qiu Y, Marquez-Curtis LA, Janowska-Wieczorek A. 2012. Mesenchymal stromal cells derived from umbilical cord blood migrate in response to complement C1q. Cytotherapy 14:285-295.
99. Ramot Y, Meiron M, Toren A, Steiner M, Nyska A. 2009. Safety and biodistribution profile of placental-derived mesenchymal stromal cells (PLX-PAD) following intramuscular delivery. Toxicol Pathol 37:606-616.
100. Reddy S, Wasnik S, Guha A, Kumar JM, Sinha A, Singh S. 2012. Evaluation of nano-biphasic calcium phosphate ceramics for bone tissue engineering applications: In vitro and preliminary in vivo studies. J Biomater Appl Epub ahead of printing, January 27.
101. Romanov YA, Svintsitskaya VA, Smirnov VN. 2003. Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord. Stem Cells (Dayton, Ohio) 21:105-110.
102. Roseti L, Serra M, Tigani D, Brognara I, Lopriore A, Bassi A, Fornasari PM. 2008. Cell manipulation in autologous chondrocyte implantation: From research to cleanroom. Chir Organi Mov 91:147-151.
103. Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE. 1993. Stored placental blood for unrelated bone marrow reconstitution. Blood 81:1679-1690.
104. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. 2005. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells (Dayton, Ohio) 23:220-229.
105. Schmidt A, Ladage D, Schinkothe T, Klausmann U, Ulrichs C, Klinz FJ, Brixius K, Arnhold S, Desai B, Mehlhorn U, Schwinger RH, Staib P, Addicks K, Bloch W. 2006. Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells (Dayton, Ohio) 24:1750-1758.
106. Secco M, Zucconi E, Vieira NM, Fogaca LL, Cerqueira A, Carvalho MD, Jazedje T, Okamoto OK, Muotri AR, Zatz M. 2008. Multipotent stem cells from umbilical cord: Cord is richer than blood! Stem Cells (Dayton, Ohio) 26:146-150.
107. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ. 2002. Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells (Dayton, Ohio) 20:530-541.
108. Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrodder H, Jensen T, Kassem M. 2004. Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23:5095-5098.
109. Seshareddy K, Troyer D, Weiss ML. 2008. Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord. Methods Cell Biol 86:101-119.
110. Shao X, Goh JC, Hutmacher DW, Lee EH, Zigang G. 2006. Repair of large articular osteochondral defects using hybrid scaffolds and bone marrow-derived mesenchymal stem cells in a rabbit model. Tissue Eng 12:1539-1551.
111. Sharma B, Williams CG, Khan M, Manson P, Elisseeff JH. 2007. In vivo chondrogenesis of mesenchymal stem cells in a photopolymerized hydrogel. Plast Reconstr Surg 119:112-120.
112. Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A, Wengler GS, Parolini O. 2007. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 1:296-305.
113. Stenderup K, Justesen J, Clausen C, Kassem M. 2003. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33:919-926.
114. Stolzing A, Scutt A. 2006. Age-related impairment of mesenchymal progenitor cell function. Aging Cell 5:213-224.
115. Sun H, Feng K, Hu J, Soker S, Atala A, Ma PX. 2010. Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials 31:1133-1139.
116. Tavassoli M, Crosby WH. 1968. Transplantation of marrow to extramedullary sites. Science 161:54-56.
117. Teng IW, Hou PC, Lee KD, Chu PY, Yeh KT, Jin VX, Tseng MJ, Tsai SJ, Chang YS, Wu CS, Sun HS, Tsai KD, Jeng LB, Nephew KP, Huang TH, Hsiao SH, Leu YW. 2011. Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res 71:4653-4663.
118. Todorov P, Hristova E, Konakchieva R, Michova A, Dimitrov J. 2010. Comparative studies of different cryopreservation methods for mesenchymal stem cells derived from human fetal liver. Cell Biol Int 34:455-462.
119. Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M, Mortier C, Bron D, Lagneaux L. 2005. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: Proliferation, Oct4 expression, and plasticity. Stem Cells (Dayton, Ohio) 23:1105-1112.
120. Troyer DL, Weiss ML. 2008. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells (Dayton, Ohio) 26:591-599.
121. van Buul GM, Kotek G, Wielopolski PA, Farrell E, Bos PK, Weinans H, Grohnert AU, Jahr H, Verhaar JA, Krestin GP, van Osch GJ, Bernsen MR. 2011. Clinically translatable cell tracking and quantification by MRI in cartilage repair using superparamagnetic iron oxides. PLoS ONE 6:e17001.
122. van de Ven C, Collins D, Bradley MB, Morris E, Cairo MS. 2007. The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration. Exp Hematol 35:1753-1765.
123. Wagner W, Ho AD, Zenke M. 2010. Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev 16:445-453.
124. Walter MN, Wright KT, Fuller HR, MacNeil S, Johnson WE. 2010. Mesenchymal stem cell-conditioned medium accelerates skin wound healing: An in vitro study of fibroblast and keratinocyte scratch assays. Exp Cell Res 316:1271-1281.
125. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC. 2004. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells (Dayton, Ohio) 22:1330-1337.
126. Wang L, Seshareddy K, Weiss ML, Detamore MS. 2009a. Effect of initial seeding density on human umbilical cord mesenchymal stromal cells for fibrocartilage tissue engineering. Tissue Eng A 15:1009-1017.
127. Wang L, Singh M, Bonewald LF, Detamore MS. 2009b. Signalling strategies for osteogenic differentiation of human umbilical cord mesenchymal stromal cells for 3D bone tissue engineering. J Tissue Eng Regen Med 3:398-404.
128. Wang L, Ott L, Seshareddy K, Weiss ML, Detamore MS. 2011. Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells. Regen Med 6:95-109.
129. Wang Y, Han ZB, Song YP, Han ZC. 2012. Safety of mesenchymal stem cells for clinical application. Stem Cells Int 2012:652034.
130. Wei X, Du Z, Zhao L, Feng D, Wei G, He Y, Tan J, Lee WH, Hampel H, Dodel R, Johnstone BH, March KL, Farlow MR, Du Y. 2009. IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats. Stem Cells (Dayton, Ohio) 27:478-488.
131. Wei H, Tan G, Manasi N, Qiu S, Kong G, Yong P, Koh C, Ooi TH, Lim SY, Wong P, Gan SU, Shim W. 2012. One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells. Stem Cell Res 9:87-100.
132. Weiss ML, Troyer DL. 2006. Stem cells in the umbilical cord. Stem Cell Rev 2:155-162.
133. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM. 2003. Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121:368-374.
134. Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N. 2009. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res 3:63-70.
135. Yen BL, Huang HI, Chien CC, Jui HY, Ko BS, Yao M, Shun CT, Yen ML, Lee MC, Chen YC. 2005. Isolation of multipotent cells from human term placenta. Stem Cells (Dayton, Ohio) 23:3-9.
136. Zhang X, Mitsuru A, Igura K, Takahashi K, Ichinose S, Yamaguchi S, Takahashi TA. 2006. Mesenchymal progenitor cells derived from chorionic villi of human placenta for cartilage tissue engineering. Biochem Biophys Res Commun 340:944-952.
137. Zisa D, Shabbir A, Suzuki G, Lee T. 2009. Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair. Biochem Biophys Res Commun 390:834-838.
138. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. 2001. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 7:211-228.
139. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. 2002. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13:4279-4295.